Eleanor Malone
Editor in Chief, Commercial Insights at Generics Bulletin
Editor in Chief, Commercial Insights at In Vivo
Editor in Chief, Commercial Insights at Scrip
Editor in Chief, Commercial Insights, Citeline - Scrip, In Vivo, Generics Bulletin - covering biopharma news and analysis. All views are my own.
Articles
-
1 week ago |
insights.citeline.com | Eleanor Malone
Top 10 Drugs Q1 2025: Keytruda Dominates; Mounjaro ClimbsLilly’s Mounjaro Narrows The Gap On Novo Nordisk’s Ozempic Lilly’s Mounjaro for diabetes rose from sixth to third position among the top-selling drugs in the first quarter of 2025, Rival Ozempic retained second position and Merck & Co’s immuno-oncology blockbuster Keytruda stayed far ahead. Top 10 best-selling drugs generated $37.7bn worldwide (Shutterstock)
-
2 weeks ago |
insights.citeline.com | Eleanor Malone |Edwin Elmhirst |Kosh Naran
Titans Of Pharma: Lilly’s Ricks Tops Big Pharma Pay ChartAbbVie’s Outgoing CEO Gonzalez Takes Second Place The big pharma CEO with the highest-valued compensation in 2024 was David Ricks of Eli Lilly, while Pfizer and J&J executives slipped into third and fourth place behind AbbVie's now retired chief Richard Gonzalez. European firms brought up the rear.
-
2 months ago |
insights.citeline.com | Eleanor Malone
Top-Selling Drugs 2024: Keytruda, Ozempic And Dupixent DominateMerck IO Drug Extends Lead As Obesity Drugs Climb TableMerck’s immuno-oncology blockbuster was the world’s best-selling drugs by revenues for the second year in a row, with an almost $12bn lead over its closest rival, Novo Nordisk’s GLP-1 drug Ozempic. Best-selling drugs generate billions of dollars (Shutterstock)
-
Mar 12, 2025 |
insights.citeline.com | Eleanor Malone
20 Voices: What Does 2025 Hold For Biopharma? Dealmaking, Innovation And Therapeutic BreakthroughsTwenty executives in the biopharma industry outline their expectations for key trends and developments this year. A selection of commentary from a broad industry survey by Scrip. Biopharma leaders consider key emerging trends (jittawit21/Shutterstock)
-
Feb 26, 2025 |
clinicalleader.com | Eleanor Malone
By Eleanor Malone As the biopharmaceutical industry approaches 2025, clinical trials are set to undergo transformative changes, emphasizing patient-centricity and inclusivity. Here we explore emerging trends that leverage technological advancements, including artificial intelligence (AI) and data analytics, to enhance trial efficiency and accuracy.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 2K
- Tweets
- 3K
- DMs Open
- No
RT @SarahKarlin: heading to the Senate this afternoon for the Bernie-Insulin makers-PBM showdown.
A group of us @citeline and @norstella are taking part in #RaceforLife in memory of our colleague Maureen Kenny - @scripregmaureen - and we would love to raise as much as possible for cancer research... https://t.co/RoQujzw6VJ
My brilliant, funny, lovely dad.
Andrew Malone obituary https://t.co/rQ1H2YtE5H